Atlas Trials

Recurrent Mycosis Fungoides and Sezary Syndrome

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Mycosis Fungoides and Sezary Syndrome

RecordFirmDate
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment (NCT04541017)National Cancer Institute (NCI)2021-04-06
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma (NCT03063632)National Cancer Institute (NCI)2017-12-14
Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma (NCT02548468)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2015-11-20
Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome (NCT02243579)National Cancer Institute (NCI)2014-10-15
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709)National Cancer Institute (NCI)2012-04-16
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors (NCT01326702)National Cancer Institute (NCI)2011-07-01
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578)National Cancer Institute (NCI)2010-11-24
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery (NCT00608361)National Cancer Institute (NCI)2008-10-01

Track Recurrent Mycosis Fungoides and Sezary Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.